Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Cellular and subcellular localization of PKMζ.

Hernández AI, Oxberry WC, Crary JF, Mirra SS, Sacktor TC.

Philos Trans R Soc Lond B Biol Sci. 2013 Dec 2;369(1633):20130140. doi: 10.1098/rstb.2013.0140. Print 2014 Jan 5.

2.

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.

Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ.

Alzheimers Dement. 2012 Jan;8(1):1-13. doi: 10.1016/j.jalz.2011.10.007.

3.

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.

Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT; National Institute on Aging; Alzheimer’s Association.

Acta Neuropathol. 2012 Jan;123(1):1-11. doi: 10.1007/s00401-011-0910-3. Epub 2011 Nov 20.

4.

Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's disease.

Shao CY, Mirra SS, Sait HB, Sacktor TC, Sigurdsson EM.

Acta Neuropathol. 2011 Sep;122(3):285-92. doi: 10.1007/s00401-011-0843-x. Epub 2011 Jun 1.

5.

Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.

Fillenbaum GG, van Belle G, Morris JC, Mohs RC, Mirra SS, Davis PC, Tariot PN, Silverman JM, Clark CM, Welsh-Bohmer KA, Heyman A.

Alzheimers Dement. 2008 Mar;4(2):96-109. doi: 10.1016/j.jalz.2007.08.005.

6.

Aberrantly regulated proteins in frontotemporal dementia.

Schweitzer K, Decker E, Zhu L, Miller RE, Mirra SS, Spina S, Ghetti B, Wang M, Murrell J.

Biochem Biophys Res Commun. 2006 Sep 22;348(2):465-72. Epub 2006 Jul 28.

PMID:
16890190
7.

Atypical protein kinase C in neurodegenerative disease II: PKCiota/lambda in tauopathies and alpha-synucleinopathies.

Shao CY, Crary JF, Rao C, Sacktor TC, Mirra SS.

J Neuropathol Exp Neurol. 2006 Apr;65(4):327-35.

PMID:
16691114
8.

Atypical protein kinase C in neurodegenerative disease I: PKMzeta aggregates with limbic neurofibrillary tangles and AMPA receptors in Alzheimer disease.

Crary JF, Shao CY, Mirra SS, Hernandez AI, Sacktor TC.

J Neuropathol Exp Neurol. 2006 Apr;65(4):319-26.

PMID:
16691113
9.

Nuclear pore complex proteins in Alzheimer disease.

Sheffield LG, Miskiewicz HB, Tannenbaum LB, Mirra SS.

J Neuropathol Exp Neurol. 2006 Jan;65(1):45-54.

PMID:
16410748
10.

Recognition: Robert Terry.

Mirra SS.

Alzheimers Dement. 2005 Jul;1(1):79. doi: 10.1016/j.jalz.2005.06.017. No abstract available.

PMID:
19595825
11.

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I; Office of Rare Diseases of the National Institutes of Health.

J Neuropathol Exp Neurol. 2002 Nov;61(11):935-46.

PMID:
12430710
12.

Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis.

Atzori C, Ghetti B, Piva R, Srinivasan AN, Zolo P, Delisle MB, Mirra SS, Migheli A.

J Neuropathol Exp Neurol. 2001 Dec;60(12):1190-7.

PMID:
11764091
13.

Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study.

Wolf DS, Gearing M, Snowdon DA, Mori H, Markesbery WR, Mirra SS.

Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13(4):226-31.

PMID:
10609672
14.

The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series.

Tsuang D, Larson EB, Bowen J, McCormick W, Teri L, Nochlin D, Leverenz JB, Peskind ER, Lim A, Raskind MA, Thompson ML, Mirra SS, Gearing M, Schellenberg GD, Kukull W.

Arch Neurol. 1999 Dec;56(12):1489-95.

PMID:
10593304
15.

Apolipoprotein E and the neuropathology of Alzheimer's disease.

Mirra SS.

Hum Pathol. 1999 Oct;30(10):1125-7. No abstract available.

PMID:
10534156
16.

Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX.

Heyman A, Fillenbaum GG, Gearing M, Mirra SS, Welsh-Bohmer KA, Peterson B, Pieper C.

Neurology. 1999 Jun 10;52(9):1839-44.

PMID:
10371532
17.

Tau pathology in a family with dementia and a P301L mutation in tau.

Mirra SS, Murrell JR, Gearing M, Spillantini MG, Goedert M, Crowther RA, Levey AI, Jones R, Green J, Shoffner JM, Wainer BH, Schmidt ML, Trojanowski JQ, Ghetti B.

J Neuropathol Exp Neurol. 1999 Apr;58(4):335-45.

PMID:
10218629
18.

Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups.

Gearing M, Lynn M, Mirra SS.

Arch Neurol. 1999 Feb;56(2):203-8.

PMID:
10025425
19.

Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease.

Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, Peterson BL, Pieper CF.

Neurology. 1998 Jul;51(1):159-62. Erratum in: Neurology 1998 Dec;51(6):1809.

PMID:
9674796
20.

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM.

Arch Neurol. 1998 Mar;55(3):326-35.

PMID:
9520006
21.

A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase.

Melov S, Schneider JA, Day BJ, Hinerfeld D, Coskun P, Mirra SS, Crapo JD, Wallace DC.

Nat Genet. 1998 Feb;18(2):159-63.

PMID:
9462746
22.
23.

Neuropathologic assessment of Alzheimer's disease.

Mirra SS, Gearing M, Nash F.

Neurology. 1997 Sep;49(3 Suppl 3):S14-6. No abstract available.

PMID:
9310508
24.

Brain infarction and the clinical expression of Alzheimer disease.

Mirra SS, Gearing M.

JAMA. 1997 Jul 9;278(2):113; author reply 114. No abstract available.

PMID:
9214519
26.

Presenilin-1 protein expression in familial and sporadic Alzheimer's disease.

Levey AI, Heilman CJ, Lah JJ, Nash NR, Rees HD, Wakai M, Mirra SS, Rye DB, Nochlin D, Bird TD, Mufson EJ.

Ann Neurol. 1997 Jun;41(6):742-53.

PMID:
9189035
27.

Corticobasal degeneration: neuropathologic and clinical heterogeneity.

Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS.

Neurology. 1997 Apr;48(4):959-69.

PMID:
9109885
28.
29.

beta-Amyloid (A beta) deposition in the brains of aged orangutans.

Gearing M, Tigges J, Mori H, Mirra SS.

Neurobiol Aging. 1997 Mar-Apr;18(2):139-46.

PMID:
9258890
30.

Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases.

Hulette C, Nochlin D, McKeel D, Morris JC, Mirra SS, Sumi SM, Heyman A.

Neurology. 1997 Mar;48(3):668-72.

PMID:
9065545
31.

Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.

Ishii K, Tamaoka A, Mizusawa H, Shoji S, Ohtake T, Fraser PE, Takahashi H, Tsuji S, Gearing M, Mizutani T, Yamada S, Kato M, St George-Hyslop PH, Mirra SS, Mori H.

Brain Res. 1997 Feb 14;748(1-2):250-2.

PMID:
9067471
32.
33.

A beta40 is a major form of beta-amyloid in nonhuman primates.

Gearing M, Tigges J, Mori H, Mirra SS.

Neurobiol Aging. 1996 Nov-Dec;17(6):903-8.

PMID:
9363802
34.

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH.

Neurology. 1996 Nov;47(5):1113-24. Review.

PMID:
8909416
35.

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, Heyman A.

Neurology. 1996 Jun;46(6):1592-6.

PMID:
8649554
36.

Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease.

Gearing M, Mori H, Mirra SS.

Ann Neurol. 1996 Mar;39(3):395-9.

PMID:
8602762
37.

Regional variation in the distribution of apolipoprotein E and A beta in Alzheimer's disease.

Gearing M, Schneider JA, Robbins RS, Hollister RD, Mori H, Games D, Hyman BT, Mirra SS.

J Neuropathol Exp Neurol. 1995 Nov;54(6):833-41.

PMID:
7595656
38.

Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates.

Gearing M, Schneider JA, Rebeck GW, Hyman BT, Mirra SS.

Neurology. 1995 Nov;45(11):1985-90.

PMID:
7501146
39.

Ubiquitin-positive CA2/3 neurites in hippocampus coexist with cortical Lewy bodies.

Kim H, Gearing M, Mirra SS.

Neurology. 1995 Sep;45(9):1768-70.

PMID:
7675245
40.

Slowly progressive apraxia in Alzheimer's disease.

Green RC, Goldstein FC, Mirra SS, Alazraki NP, Baxt JL, Bakay RA.

J Neurol Neurosurg Psychiatry. 1995 Sep;59(3):312-5.

41.

Apolipoprotein E genotype in diverse neurodegenerative disorders.

Schneider JA, Gearing M, Robbins RS, de l'Aune W, Mirra SS.

Ann Neurol. 1995 Jul;38(1):131-5.

PMID:
7611717
42.

Practical topics in neuropathology. College of American Pathologists Neuropathology Committee.

Mirra SS.

Arch Pathol Lab Med. 1995 Apr;119(4):299-301. No abstract available.

PMID:
7726722
43.
44.

Autopsy practices at CERAD and Alzheimer disease center sites: a survey of neuropathologists.

Cochran EJ, Gostanian OM, Mirra SS.

Alzheimer Dis Assoc Disord. 1995 Winter;9(4):203-7.

PMID:
8749608
45.

The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease.

Davis PC, Gearing M, Gray L, Mirra SS, Morris JC, Edland SD, Lin T, Heyman A.

Neurology. 1995 Jan;45(1):178-9.

PMID:
7824112
46.

Neuropathologic correlates of persistent neurologic deficit in lithium intoxication.

Schneider JA, Mirra SS.

Ann Neurol. 1994 Dec;36(6):928-31.

PMID:
7998783
47.

Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease.

Gearing M, Rebeck GW, Hyman BT, Tigges J, Mirra SS.

Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9382-6.

48.

Progressive supranuclear palsy: neuropathologic and clinical heterogeneity.

Gearing M, Olson DA, Watts RL, Mirra SS.

Neurology. 1994 Jun;44(6):1015-24.

PMID:
8208392
49.

Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys.

Poduri A, Gearing M, Rebeck GW, Mirra SS, Tigges J, Hyman BT.

Am J Pathol. 1994 Jun;144(6):1183-7.

50.

The brain in older persons with and without dementia: findings on MR, PET, and SPECT images.

Davis PC, Mirra SS, Alazraki N.

AJR Am J Roentgenol. 1994 Jun;162(6):1267-78. Review.

PMID:
8191980

Supplemental Content

Loading ...
Support Center